JAMA

Research & Knowledge

JAMA published findings showing that focal therapy use increased in favorable intermediate-risk disease and decreased in unfavorable intermediate-, high-, and very-high-risk disease from 2010 to 2023 in nonmetastatic prostate cancer.

Reported by JAMA

Research & Knowledge

JAMA published a multicenter randomized clinical trial showing that longer cooling durations for therapeutic hypothermia in comatose survivors of cardiac arrest at 33°C did not improve neurological outcomes compared with shorter durations.

Reported by JAMA

Research & Knowledge

JAMA Insights highlights that clinicians can address both obesity and sleep health by asking patients about sleep quality and duration and advising at least 7 hours of sleep per night along with healthy diet and regular exercise.

Reported by JAMA

Research & Knowledge

JAMA published a review discussing risk factors, staging, and treatment for Classic Hodgkin Lymphoma, with cure achieved in up to 90% of treated patients with both early-stage and advanced-stage disease.

Reported by JAMA

Research & Knowledge

JAMA Deputy Editors Linda Brubaker and Preeti Malani discussed the latest science published in JAMA regarding respiratory vaccine effectiveness and safety, Evolocumab for LDL lowering before percutaneous coronary intervention, and digital outreach to increase statin refills.

Reported by JAMA

Research & Knowledge

JAMA published an article discussing how simple, direct, and precise language may help clinicians communicate brain death as legal death and reduce confusion during evaluation and determination.

Reported by JAMA

Research & Knowledge

JAMA+ Trials Theme of the Month examines ongoing confusion and debate in pragmatic trial research

Reported by JAMA